/
•
•
Detailed stories on technology startups, business and economic current affairs.
As of the end of December, the lender’s gross non-performing assets ratio was 1.26%, compared to 1.23% a year ago and 1.34% in the September quarter.

As of the end of December, the lender’s gross non-performing assets ratio was 1.26%, compared to 1.23% a year ago and 1.34% in the September quarter.

The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
A regulatory easing could see the billionaire’s conglomerate move from running airports to owning an airline—an idea he is warming up to, with multiple options open.
The Bengaluru-based contract manufacturer lands in legal hot water with the California-headquartered transformer startup over a trade secret dispute.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
A regulatory easing could see the billionaire’s conglomerate move from running airports to owning an airline—an idea he is warming up to, with multiple options open.
The Bengaluru-based contract manufacturer lands in legal hot water with the California-headquartered transformer startup over a trade secret dispute.